Proteasome inhibitor delanzomib for use in the treatment of lupus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9340559
APP PUB NO 20130345174A1
SERIAL NO

14002249

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method for treating lupus in a subject, comprising the step of administering to the subject Compound A.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CEPHALON INC145 BRANDYWINE PARK WEST CHESTER PA 19380

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ruggeri, Bruce A West Chester, US 11 119
Seavey, Matthew M Secane, US 7 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00